Suppr超能文献

肾内多巴胺-1受体控制肾功能。

Intrarenal dopamine-1 receptors control renal function.

作者信息

Siragy H M, Felder R A, Howell N L, Chevalier R L, Peach M J, Carey R M

机构信息

Department of Internal Medicine, University of Virginia School of Medicine, Charlottesville 22908.

出版信息

Trans Assoc Am Physicians. 1988;101:288-91.

PMID:2978636
Abstract

Dopamine receptors are classified to DA-1 and DA-2 and are characterized in renal tissue by radioligand binding and by the response of renal adenylate cyclase to dopaminergic agonists and antagonists. DA-1 receptors are localized in the renal tubules, the medial layer of renal microvessels, and the juxtaglomerular apparatus. DA-1 receptor stimulation causes dilation of renal, mesenteric, coronary, and cerebral vessels. In the present study, we tested the hypothesis that dopamine is a paracrine substance in the control of renal function. We employed a potent specific DA-1 receptor antagonist, SCH, to evaluate the role of intrarenal DA-1 receptor in the maintenance of renal function. Intrarenal DA-1 receptor blockade with SCH caused a highly significant dose-dependent antidiuresis and antinatriuresis, and decreased FENa. A rebound diuresis and natriuresis above control values were observed after cessation of DA-1 receptor blockade. There were no changes in renal hemodynamic function during DA-1 receptor blockade. These results strongly suggest that the antinatriuresis and antidiuresis induced by DA-1 receptor blockade are mediated by an action at the renal tubule. The infusion rate of SCH administered intrarenally was sufficiently low to produce no measurable systemic effects including PRA, PAC, and MAP. Thus, these results can be interpreted as due to intrarenal DA-1 blockade. In summary, we have demonstrated that renal excretory function is highly sensitive to DA-1 receptor blockade within the kidney and appears to be mediated by renal tubular events. This study provides strong evidence that DA-1 receptors play a physiological role in the control of renal function.

摘要

多巴胺受体分为DA - 1和DA - 2两类,通过放射性配体结合以及肾腺苷酸环化酶对多巴胺能激动剂和拮抗剂的反应在肾组织中得以表征。DA - 1受体定位于肾小管、肾微血管中层和球旁器。刺激DA - 1受体可导致肾、肠系膜、冠状动脉和脑血管扩张。在本研究中,我们检验了多巴胺是控制肾功能的旁分泌物质这一假说。我们使用了一种强效特异性DA - 1受体拮抗剂SCH,以评估肾内DA - 1受体在维持肾功能中的作用。用SCH阻断肾内DA - 1受体导致了高度显著的剂量依赖性抗利尿和利钠作用,并降低了滤过钠排泄分数(FENa)。在停止DA - 1受体阻断后,观察到利尿和利钠作用反跳至高于对照值。在DA - 1受体阻断期间,肾血流动力学功能没有变化。这些结果强烈表明,DA - 1受体阻断所诱导的利钠和利尿作用是由肾小管的作用介导的。经肾内给予的SCH输注速率足够低,不会产生包括肾素活性(PRA)、醛固酮(PAC)和平均动脉压(MAP)在内的可测量的全身效应。因此,这些结果可解释为是由于肾内DA - 1阻断所致。总之,我们已经证明,肾排泄功能对肾内DA - 1受体阻断高度敏感,并且似乎是由肾小管事件介导的。这项研究提供了强有力的证据,表明DA - 1受体在肾功能控制中发挥生理作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验